Showing results (21-30 of 148) with videos related to
Sort By:
Pageof 15
Annals of the Rheumatic Diseases|May 1, 1996
Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritisI B McInnes, D Porter, E A Murphy, et al.British Journal of Rheumatology|November 1, 1995
Clinical efficacy of sulphasalazine--a reviewH A CapellThe Journal of Rheumatology. Supplement|June 21, 2001
Disease modifying antirheumatic drugs: longterm safety issuesH A CapellClinical Rheumatology|March 1, 1984
Oral gold: a comparison with placebo and with intramuscular sodium aurothiomalateD Lewis, H A CapellBritish Journal of Rheumatology|August 1, 1986
An acute arthritis clinic--one year's experienceJ D Parker, H A CapellLupus|June 1, 1996
The use of antimalarials in combination with other disease modifying agents in RA--the British experienceM R Duncan, H A CapellEuropean Journal of Rheumatology and Inflammation|January 1, 1983
Adrenal response in rheumatoid arthritis treated with long-term steroidsT Pullar, R D SturrockInternational Journal of Clinical Practice|June 13, 2003
Etoricoxib in the treatment of chronic painM R Duncan, H A CapellBailliere'S Clinical Rheumatology|April 1, 1987
Drug treatment of pain in rheumatoid disordersH A Capell, S M FraserPageof 15